Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance

Atherosclerosis

Volumn 226, Issue 1, 2013, Pages 140-145

  Bacci, Simonetta ^a   Prudente, Sabrina ^a   Copetti, Massimiliano ^a   Spoto, Belinda ^b   Rizza, Stefano ^c   Baratta, Roberto ^d   Di Pietro, Natalia ^e   Morini, Eleonora ^f   Di Paola, Rosa ^a   Testa, Alessandra ^b   Mallamaci, Francesca ^b   Tripepi, Giovanni ^b   Zhang, Yuan Yuan ^g   Mercuri, Luana ^a   Di Silvestre, Sara ^e   Lauro, Renato ^c   Malatino, Lorenzo ^h   Consoli, Agostino ^e   Pellegrini, Fabio ^a,i   Pandolfi, Assunta ^e   Frittitta, Lucia ^d   Zoccali, Carmine ^b   Federici, Massimo ^c   Doria, Alessandro ^g   Trischitta, Vincenzo ^a,f   more..

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b CNR Consiglio Nazionale delle Ricerche   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

^e UNIVERSITY OF CHIETI   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g JOSLIN DIABETES CENTER   (United States)

^h UNIVERSITY OF CATANIA   (Italy)

ⁱ Laboratory of Clinical Epidemiology of Diabetes and Chronic Diseases   (Italy)

Author keywords

Genetic susceptibility; Insulin dependent endothelial function; Insulin sensitivity; Nonsynonymous polymorphism

Indexed keywords

GLUCOSE; INSULIN; NITRIC OXIDE SYNTHASE;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENPP1 GENE; ENZYME ACTIVITY; FEMALE; GENE; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; IRS1 GENE; MAJOR CLINICAL STUDY; MALE; OBESITY; ONSET AGE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRIB3 GENE; UMBILICAL VEIN ENDOTHELIAL CELL;

CARDIOVASCULAR DISEASES; CELLS, CULTURED; CROSS-SECTIONAL STUDIES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; PROSPECTIVE STUDIES; SIGNAL TRANSDUCTION;

EID: 84871377335     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.10.035     Document Type: Article

References (33)

1. Lloyd-Jones D., Adams R.J., Brown T.M., et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010, 121:e46-e215. Writing Group Members.
2. Hamsten A., Erikson P. Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimism. J Intern Med 2008, 263:538-552.
3. McPherson R., Pertsemlidis A., Kavaslar N., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007, 316:1488-1491.
4. Helgadottir A., Thorleifsson G., Manolescu A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007, 316:1491-1493.
5. Samani N.J., Erdmann J., Hall A.S., et al. Genomewide association analysis of coronary artery disease. N Engl J Med 2007, 357:443-453.
6. Erdmann J., Grosshennig A., Braund P.S., et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 2009, 41:280-282.
7. Kathiresan B., Voight B.F., Purcell S., et al. Genome-wide association of early-onset myocardial infarction with common single polymorphisms, common copy number variants, and rare copy number variants. Nat Genet 2009, 41:334-341. Myocardial Infarction Genetics Consortium.
8. Reilly M.P., Li M., He J., et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 2011, 377:383-392.
9. Coronary Artery Disease (C4D) Genetics Consortium A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet 2011, 43:339-344.
10. Howard G., O'Leary D.H., Zaccaro D., et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) investigators. Circulation 1996, 93:1809-1817.
11. Rutter M.K., Meigs G.B., Sullivan M.L., D'Agostino R.B., Wilson P.W. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 2005, 54:3252-3257.
12. Rich S.S., Bowden D.W., Haffner S.M., et al. Identification of quantitative trait loci for glucose homeostasis: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 2004, 53:1866-1875. Insulin Resistance Atherosclerosis Study Family Study.
13. Prudente S., Morini E., Trishitta V. Insulin signaling regulating genes: effect on T2DM and cardiovascular risk. Nat Rev Endocrinol 2009, 5:682-693.
14. Pizzuti A., Frittitta L., Argiolas A., et al. A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes 1999, 48:1881-1884.
15. Costanzo B.V., Trischitta V., Di Paola R., et al. The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121). Diabetes 2001, 50:831-836.
16. Bacci S., Di Paola R., Menzaghi C., et al. ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling and nitric oxide synthase activity in endothelial cells. Arterioscler Thromb Vasc Biol 2009, 29:1678-1683.
17. Almind K., Inoue G., Pedersen O., Kahn C.R. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. J Clin Invest 1996, 97:2569-2575.
18. Federici M., Pandolfi A., De Filippis E.A., et al. G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells. Circulation 2004, 109:399-405.
19. Prudente S., Hribal M.L., Flex E., et al. The functional Q84R polymorphism of mammalian tribbles homolog TRB3 is associated with insulin resistance and related cardiovascular risk in Caucasians from Italy. Diabetes 2005, 54:2807-2811.
20. Andreozzi F., Formoso G., Prudente S., et al. TRIB3 R84 variant is associated with impaired insulin mediated nitric oxide production in human endothelial cells. Arterioscler Thromb Vasc Biol 2008, 28:1355-1360.
21. Liew C.W., Bochenski J., Kawamori D., et al. The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells. J Clin Invest 2010, 120:2876-2888.
22. Abate N., Chandalia M., Satija P., et al. ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes. Diabetes 2005, 54:1207-1213.
23. Stolerman E.S., Manning A.K., McAteer J.B., et al. Haplotype structure of the ENPP1 Gene and nominal association of the K121Q missense single nucleotide polymorphism with glycemic traits in the Framingham heart study. Diabetes 2008, 57:1971-1977.
24. Baratta R., Rossetti P., Prudente S., et al. Role of the ENPP1 K121Q polymorphism on glucose homeostasis. Diabetes 2008, 57:3360-3364.
25. Clausen J.O., Hansen T., Bjørbaek C., et al. Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 1995, 346:397-402.
26. Prudente S., Baratta R., Andreozzi F., et al. TRIB3 R84 variant affects glucose homeostasis by altering the interplay between insulin sensitivity and secretion. Diabetologia 2010, 53:1354-1361.
27. Grarup N., Urhammer S.A., Ek J., et al. Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects. Diabetologia 2006, 49:2097-2104.
28. Yu Q., Gao F., Ma X.L. Insulin says NO to cardiovascular disease. Cardiovas Res 2011, 89:516-524.
29. Bacci S., Rizza S., Prudente S., et al. The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals. Evidence for interaction with obesity in diabetic patients. Diabetes 2011, 60:1000-1007.
30. Rask-Madsen C., Li Q., Freund B., et al. Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab 2010, 11:379-389.
31. Scherer P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006, 55:1537-1545.
32. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group Recommendations from the EGAPP working group: genomic profiling to assess cardiovascular risk to improve cardiovascular health. Genet Med 2010, 12:839-843.
33. Wang Y., Beydoun M.A., Liang L., et al. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obes (Silver Spring) 2008, 16:2323-2330.